After years of relying on 5FU, colorectal cancer clinicians now have a wealth of targeted therapies and combination protocols to choose from. The question is, what to use in which patients and when?
Related Articles
Cutting Edge
Don’t shoot the driver! It’s about taxonomy more than targets
Senza categoria
Newsround
Senza categoria